Recalls / Class I

Class ID-1367-2015

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Mucinex Fast Max Severe Congestion & Cough, Maximum Strength, Dextromethorphan HBr Cough Suppressant, Guaifenesin Expectorant, Phenylephrine HCl Nasal Decongestant, 6 fl oz (180 mL) Bottle, For Age 12+, Dist. By: Reckitt Benckiser Parsippany, NJ 07054-0224, Made in India, NDC 63824-014-66, UPC 6382401465-4

Affected lot / code info: Lot #: Exp: MSC0049 8/31/2016 MSC0050 8/31/2016 MSC0051 8/31/2016 MSC0052 8/31/2016 MSC0053 8/31/2016 MSC0054 8/31/2016 MSC0055 8/31/2016 MSC0056 9/30/2016 MSC0057 9/30/2016 MSC0058 9/30/2016 MSC0059 10/31/2016 MSC0060 10/31/2016 MSC0061 10/31/2016 MSC0062 10/31/2016 MSC0063 10/31/2016 MSC0064 10/31/2016 MSC0065 10/31/2016 MSC0066 10/30/2016 MSC0067 11/30/2016 MSC0068 11/30/2016 MSC0069 11/30/2016 MSC0070 11/30/2016 MSC0071 11/30/2016 MSC0073 11/30/2016 MSC0074 11/30/2016 MSC0075 11/30/2016 MSC0076 11/30/2016 MSC0077 12/31/2016 MSC0078 12/31/2016 MSC0079 12/31/2016 MSC0080 12/31/2016 MSC0082 12/31/2016

Why it was recalled

Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.

Recalling firm

Firm: Reckitt Benckiser LLC
Notification channel: Letter
Type: Voluntary: Firm initiated
Address: 399 Interpace Pkwy, N/A, Parsippany, New Jersey 07054-1133

Distribution

Quantity: 200,688 Bottles
Distribution pattern: Nationwide

Timeline

Recall initiated: 2015-04-15
FDA classified: 2015-08-25
Posted by FDA: 2015-09-02
Terminated: 2018-03-09
Status: Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1367-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.